Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Open To M&A Moves, Closed To Board Seat For Activist Investor

Executive Summary

P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. A few days after releasing its results, company appeals to shareholders to vote against an activist investor's bid for a board seat.

You may also be interested in...



P&G Extends Gum Repair Toothpaste Line As It Trims Production Footprint

P&G says harmful plaque bacteria below the gum line evades "even the most the diligent brushers." The firm plans in 2020 to move manufacturing of hair, oral and personal care products from Iowa to a facility in West Virginia.

P&G Extends Gum Repair Toothpaste Line As It Trims Production Footprint

P&G says harmful plaque bacteria below the gum line evades "even the most the diligent brushers." The firm plans in 2020 to move manufacturing of hair, oral and personal care products from Iowa to a facility in West Virginia.

P&G Board Seat Swings To Peltz In Ongoing Vote Tally

P&G says results from an independent tabulator indicate Trian Fund head Nelson Peltz is leading the firm's candidate, Ernesto Zedillo, in a board proxy vote by around 42,780 shares, or 0.0016% of total outstanding shares. But P&G says the vote count isn't completed.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel